INTELLIGENT BIO SOLUTIONS INC. (INBS) — Institutional Holders, Q2 2026
8 institutional investment managers reported a INBS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $416.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
INBS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- ARMISTICE CAPITALAdded · +11,397 sh+$26.2K
- UBS Group AGAdded · +5,363 sh+$12.3K
- Tower Research Capital (TRC)Added · +2,030 sh+$4.7K
- BARCLAYS PLCNew · +142 sh+$326.00
Biggest sellers
- Alyeska Investment Group, L.P.Sold out · -37,956 sh-$87.1K
- GEODE CAPITAL MANAGEMENTTrimmed · -7,769 sh-$17.8K
- CURIO WEALTHSold out · -200 sh-$459.00
INBS 13F holders ranked 1–8 of 8
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL#1 · 141,397 sh | 141,397 | $324.5K | <0.01% | +8.8% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 20,840 sh | 20,840 | $47.8K | 0.00% | -27.2% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 5,810 sh | 5,810 | $13.3K | 0.00% | 0.0% |
| 4 | UBS Group AG#4 · 5,735 sh | 5,735 | $13.2K | 0.00% | +1441.7% |
| 5 | VANGUARD FIDUCIARY#5 · 3,958 sh | 3,958 | $9.1K | 0.00% | 0.0% |
| 6 | Tower Research Capital (TRC)#6 · 3,280 sh | 3,280 | $7.5K | <0.01% | +162.4% |
| 7 | OSAIC#7 · 200 sh | 200 | $460.00 | 0.00% | 0.0% |
| 8 | BARCLAYS PLC#8 · 142 sh | 142 | $326.00 | 0.00% | New |
Funds that sold out of INBS in Q2 2026 (2)
Held INBS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Alyeska Investment Group, L.P.37,956 sh | 37,956 | $127.0K |
| CURIO WEALTH200 sh | 200 | $669.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.